Toh et al. also showed that restraining of MTA1 function or expression augmented the sensitivity of cancer cells to chemotherapy by retrieving function of P53 as a tumor-suppressor gene or by preventing tumor angiogenesis by stabilizing HIF-1α (7). This evidence concerns the gene TP53 and neoplasm.